कोशिश गोल्ड - मुक्त
PLI boost: Cancer drugs to cost less
Mint Kolkata
|March 05, 2025
Cancer patients facing prohibitive treatment costs in India can hope for relief.
The nation's top drugmakers have started manufacturing key medicines for such diseases in the country.
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd, Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under the production-linked incentive (PLI) scheme, according to information shared by the department of pharmaceuticals with Mint. They are among the 55 companies selected for incentives to produce 175 high-value medicines in India.
At present, most cancer drugs are imported, making them prohibitively expensive. That's when India's cancer burden is expected to rise from 26.7 million life years or DALYS―the sum of healthy life lost to a disease-in 2021 to 29.8 million in 2025, according to data from the Indian Council of Medical Research (ICMR) disability-adjusted The PLI scheme is a "great boon" as cancer drugs will not only become cheaper in India, but South American and southern African nations will also benefit, said Shyam Aggarwal, chairperson, medical oncology department at Sir Ganga Ram Hospital, Delhi.
यह कहानी Mint Kolkata के March 05, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Kolkata से और कहानियाँ
Mint Kolkata
When LLMs learn to take shortcuts, they become evil
Some helpful parenting tips: it is very easy to accidentally teach your children lessons you did not intend to pass on.
2 mins
November 28, 2025
Mint Kolkata
Investors expect AI use to soar. That's not happening
An uncertain outlook for interest rates. Businesses may be holding off on investment until the fog clears. In addition, history suggests that technology tends to spread in fits and starts. Consider use of the computer within American households, where the speed of adoption slowed in the late 1980s. This was a mere blip before the 1990s, when they invaded American homes.
2 mins
November 28, 2025
Mint Kolkata
Would you like to be interviewed by an AI bot instead?
don't think I want to be interviewed by a human again,\" said a 58-year-old chartered accountant who recently had an interview with a multinational company.
3 mins
November 28, 2025
Mint Kolkata
Can I claim TDS refund despite missing return filing deadline?
I am an NRI living in Dubai and have investments in Indian listed stocks. One of the companies I invested in, did a buyback in March, on which Tax Deducted at Source (TDS) was deducted. At that time, I was advised by a friend that I could claim a refund of TDS at the time of filing my tax return due to the benefits of the Double Taxation Avoidance Agreement (DTAA).
2 mins
November 28, 2025
Mint Kolkata
Tech startups on M&A route to boost scale, market share
M&As were earlier used to enter new markets or geographies, but that strategy has evolved
2 mins
November 28, 2025
Mint Kolkata
Doing India’s needy a good turn: Everyone is welcome to pitch in
What may seem weakly linked with positive outcomes on the ground could work wonders over time
3 mins
November 28, 2025
Mint Kolkata
Refiners, SCI tap Korean giants for local shipyard
Indian Oil, Bharat Petroleum and Hindustan Petroleum are part of the discussions
2 mins
November 28, 2025
Mint Kolkata
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
1 mins
November 28, 2025
Mint Kolkata
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Kolkata
What if China weaponizes its dominance of pharma inputs?
Overdependence on China for drug-making should worry the US
3 mins
November 28, 2025
Listen
Translate
Change font size

